Skip to main content
Sanofi India Ltd logo

Sanofi India Ltd — Investor Relations & Filings

Ticker · SANOFI ISIN · INE058A01010 LEI · 335800VFWLEY5V6PYH80 BSE.NS Manufacturing
Open in API
Filings indexed 1,554 across all filing types
Latest filing 2022-05-24 Proxy Solicitation & In…
Country IN India
Listing BSE.NS SANOFI

About Sanofi India Ltd

https://www.sanofi.in

Sanofi India Ltd focuses on the development, manufacturing, and marketing of a wide range of pharmaceutical products and healthcare solutions. The company operates across several therapeutic areas, including diabetes, cardiology, thrombosis, central nervous system disorders, and consumer healthcare. Its product portfolio includes established brands such as Lantus, Allegra, Combiflam, Amaryl, Avil, and Enterogermina. The organization prioritizes chronic disease management and acute care through a combination of prescription medicines and over-the-counter treatments. By integrating global research capabilities with local manufacturing excellence, the company provides specialized medical solutions aimed at improving patient health outcomes and addressing unmet medical needs.

Recent filings

Filing Released Lang Actions
Newspaper Advertisements
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a letter dated 24 May 2022 from Sanofi India Limited addressed to the Bombay Stock Exchange and National Stock Exchange of India. It announces the publication of a Postal Ballot Notice of the company, which is enclosed and published in newspapers. The content is primarily an announcement of the publication of a notice related to shareholder voting, not the notice itself or any detailed report. The document is about the publication of a voting-related notice, which fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA) or Proxy Solicitation & Information Statement (PSI). However, since it is announcing the publication of a Postal Ballot Notice (a solicitation for votes), it aligns best with Proxy Solicitation & Information Statement (PSI). The rest of the text is unrelated news content and does not affect classification. The document length is about 11,000 characters, so it is not a brief announcement but a full letter. Therefore, the classification is PSI with high confidence.
2022-05-24 English
Postal Ballot
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Postal Ballot Notice from Sanofi India Limited dated May 2022. It details the process for members to vote electronically on resolutions concerning the appointment of a new director and managing director. The document includes procedural instructions, voting timelines, and regulatory references to the Companies Act, SEBI regulations, and MCA circulars. It is not a report of voting results but a notice and invitation to vote. The content aligns with a Proxy Solicitation & Information Statement, which is used to inform shareholders and solicit votes for corporate actions. It is not an announcement of voting results (DVA), nor a management or annual report, nor a regulatory filing or earnings release. Therefore, the most appropriate classification is Proxy Solicitation & Information Statement (PSI). The document length and detail support a high confidence level.
2022-05-23 English
Further to our letter dated 13th May 2022, this is to inform that the Company is seeking approval of Members of the Company through an Ordinary Resolution for appointment of Mr. Rodolfo ....
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Postal Ballot Notice from Sanofi India Limited dated May 2022. It details the process for members to vote electronically on resolutions concerning the appointment of a new director and managing director. The document includes procedural instructions, voting timelines, and regulatory references to the Companies Act, SEBI regulations, and MCA circulars. It is not a report of voting results but a notice and explanatory statement sent to shareholders to solicit their votes via postal ballot and e-voting. This fits the category of Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings or resolutions.
2022-05-23 English
Loss of share certificate
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the loss of share certificates, citing SEBI (Listing Obligations and Disclosure Requirements) Regulations. It provides details of lost share certificates and requests the information to be taken on record. The document is short (1581 characters) and is an announcement of a specific event related to share certificates, not a financial report or detailed filing. It does not contain financial data, management discussion, or regulatory certifications. This fits the category of a Regulatory Filing (RNS), which is a general regulatory announcement that does not fit other specific categories.
2022-05-20 English
Annual General Meeting
AGM Information Classification · 95% confidence The document is titled as the minutes of the 66th Annual General Meeting (AGM) of Sanofi India Limited held on 26th April 2022. It includes details about the meeting such as attendance, directors present, auditors, voting procedures, and other procedural information typical of AGM minutes. There is no indication that this is a full annual report or financial statement, nor is it a voting results declaration or a proxy solicitation. The document is a detailed record of the AGM proceedings, which fits the definition of AGM Information (AGM-R). The document length is 7530 characters, which is consistent with a detailed AGM minutes document rather than a brief announcement or a full annual report. Therefore, the correct classification is AGM Information (AGM-R).
2022-05-20 English
Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has received communication from its ....
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges regarding the loss of share certificates, citing Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It lists details of lost share certificates and requests the information be taken on record. The document is short (1575 characters) and does not contain financial data, audit information, or report content. It is an official regulatory communication about share certificate loss, which does not fit into financial reports or management announcements. This type of document is best classified as a Regulatory Filing (RNS), which covers miscellaneous regulatory announcements and compliance documents that do not fit other categories.
2022-05-20 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.